Ibrutinib Plus Bendamustine/Rituximab (BR) Is Associated with Greater Reductions in Fatigue Than Placebo Plus BR Among Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and Fatigue Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Traina, Shana
  • Fraser, Graeme
  • Cramer, Paula
  • Silva, Rodrigo Santucci
  • Grosicki, Sebastian
  • Dilhuydy, Marie Sarah
  • Mahler, Michelle
  • Salman, Mariya
  • Howes, Angela

publication date

  • December 3, 2015

published in